PT-141 for Men: What the Research Shows, How It Differs From Sildenafil, and the Cautions

PT-141 is the development code for bremelanotide, a cyclic peptide of seven amino acids and a synthetic analogue of alpha-melanocyte-stimulating hormone. It activates melanocortin receptors, with MC1R and MC4R the two that matter at therapeutic doses; MC4R is the receptor implicated in sexual function, and animal work reviewed in the International Journal of Impotence Research in 2008 describes MC4R-driven erection in rodents. It is not a PDE5 inhibitor and does not act on the blood vessels of the penis. It is not a hormone in the endocrine sense, so it does not raise testosterone. The approved product's label states it is not indicated to enhance sexual performance.

Bremelanotide was found by accident. In the 1990s, researchers testing Melanotan II, a synthetic alpha-MSH analogue developed for sunless tanning, noticed that male volunteers reported spontaneous erections. A 1998 double-blind crossover study in the Journal of Urology followed that up in men with psychogenic erectile dysfunction. Bremelanotide is a closely related molecule taken forward as PT-141 for the sexual-function effect rather than the tanning one; a 2003 review in the Annals of the New York Academy of Sciences summarises that early programme. Its relationship to Melanotan II is covered in PT-141 vs Melanotan II.

• Desire in men. The 2004 studies measured erections in a laboratory, not sexual desire or satisfaction over months.
• Real-life use over time. These were clinic-based studies measuring response over hours.
• A phase 3 trial. None was run in men, and no bremelanotide product is approved for men.
• The compounded vial. Pepti's PT-141 is a 2 mg/mL multi-dose vial or Pen cartridge with physician-set directions; it has not been trialled. The subcutaneous doses in the men's studies are not Pepti's directions.
• Long-term safety in men. The year-long extension and the pooled safety analysis are mainly women's data.

This is the question most men are really asking. The two act on different things, and they have not been compared head to head.

If erection quality is the issue and desire is intact, a PDE5 inhibitor has far larger trials for that job, and a physician may reasonably suggest one first. Where desire itself is the question, or a PDE5 inhibitor has not been enough, PT-141 is the conversation the early studies point to. Using PT-141 alongside sildenafil or tadalafil depends on your blood pressure and cardiovascular history, so it is something to raise at intake, never to add on your own. The full benefit picture, with the limits of each study, is in PT-141 benefits.

Almost all of the percentages below come from the phase 3 trials in premenopausal women; the men's studies did not produce a side-effect table in our sources. The mechanism is the same in men, so the nausea, blood pressure and pigmentation warnings apply to everyone. The full reference is PT-141 side effects.

Never take a second dose within 24 hours. The approved label states that consecutive doses within 24 hours have not been shown to add anything and may add to the blood pressure effect.

Bremelanotide is the active ingredient of a product the FDA approved on 21 June 2019 for premenopausal women with acquired, generalised hypoactive sexual desire disorder; that label states it is not indicated in men. Because a component of an approved product may be used in 503A compounding, bremelanotide does not depend on the bulks list and was never in Category 2. A compounded PT-141 vial is a different formulation prepared by a licensed pharmacy to an individual prescription; it has not been reviewed by the FDA and is not FDA approved. Prescribing it to men rests on the early studies above plus clinical experience.

The PT-141 vial holds 10 doses. Because it is used on occasions rather than on a calendar, the beyond-use date on the label, not the dose count, governs when a vial is replaced. The Pen is dosed by its dial rather than syringe units. The combination vial adds oxytocin, whose evidence for sexual function is small and mostly from nasal spray studies: a 2014 couples study reported effects on orgasm intensity and contentment in men and women and no effect on erection, and a 2008 study in ten healthy men found no change in sexual behaviour. Details are in PT-141 + Oxytocin dosage and PT-141 dosage.

Every price is all-in, covering medication, physician review, refill management and shipping, with no membership fee. Pepti is cash-pay and does not bill insurance. Vials arrive ready to use with sterile syringes and alcohol prep pads, shipped refrigerated with ice packs. Lot test results are at /quality/lab-results. Your physician sets your directions after reviewing your intake, and they are printed on the vial.

PT-141 cannot be bought legitimately without a prescription. Sites selling it "for research use only" are not accountable for identity, purity, sterility or concentration. The prescription route:

1. Complete a free online intake covering your history, medications, blood pressure and heart history, and what has changed about desire or erections.
2. A physician licensed in your state reviews it, usually within 24 hours.
3. If it is appropriate, a PCAB-accredited, FDA-registered US 503A compounding pharmacy prepares it to that prescription.
4. It ships refrigerated with your directions printed on the vial.
5. Your physician stays reachable for questions and side effects.

Step by step: how to get PT-141 prescribed online. What to check on any provider is in where to buy PT-141 online.